AXQ Capital’s AstraZeneca AZN Stock Holding History

AXQ Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,711	Closed	-$315K	–	1001
2025 Q4	$315K	Buy	+1,711	New	+$300K	0.07%	428
2025 Q1	–	Sell	-7,884	Closed	-$1.03M	–	497
2024 Q4	$1.03M	Buy	7,884 +4,762	+153%	+$667K	0.47%	53
2024 Q3	$486K	Buy	3,122 +180	+6%	+$29.1K	0.15%	261
2024 Q2	$459K	Buy	+2,942	New	+$443K	0.11%	314
2024 Q1	–	Sell	-7,700	Closed	-$1.04M	–	624
2023 Q4	$1.04M	Sell	7,700 -3,700	-32%	-$481K	0.28%	111
2023 Q3	$1.54M	Buy	+11,400	New	+$1.56M	0.54%	32
2023 Q1	–	Sell	-7,454	Closed	-$1.01M	–	485
2022 Q4	$1.01M	Buy	+7,454	New	+$935K	0.7%	26

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

AXQ Capital's AZN Position: Q1 2026 in Review

AXQ Capital sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 1,711 shares — an estimated $315K sold.

AXQ Capital first reported a position in AZN in Q4 2022 and held it in 7 quarters. The position peaked at $1.54M in Q3 2023. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

AXQ Capital reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
AXQ Capital sold 1,711 AstraZeneca shares in Q1 2026, an estimated $315K.
AXQ Capital first reported a position in AstraZeneca in Q4 2022 and held it in 7 quarters.
AXQ Capital's AstraZeneca position peaked at $1.54M in Q3 2023.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.